FR2387240A1 - Pure human albumin recovery esp. from placental tissue - by pptn. of impurities with polyethylene glycol, for treating haemorrhage, shock etc. - Google Patents

Pure human albumin recovery esp. from placental tissue - by pptn. of impurities with polyethylene glycol, for treating haemorrhage, shock etc.

Info

Publication number
FR2387240A1
FR2387240A1 FR7723471A FR7723471A FR2387240A1 FR 2387240 A1 FR2387240 A1 FR 2387240A1 FR 7723471 A FR7723471 A FR 7723471A FR 7723471 A FR7723471 A FR 7723471A FR 2387240 A1 FR2387240 A1 FR 2387240A1
Authority
FR
France
Prior art keywords
esp
human albumin
pptn
impurities
polyethylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7723471A
Other languages
French (fr)
Other versions
FR2387240B1 (en
Inventor
Yorihiko Murata
Eizo Tsutsui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Publication of FR2387240A1 publication Critical patent/FR2387240A1/en
Application granted granted Critical
Publication of FR2387240B1 publication Critical patent/FR2387240B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Abstract

Method for recovering human albumin (I) comprises treating an aq. soln. of (I) which also contains a blood group substance with polyethyleneglycol (II) so as to ppte. protein contaminants contg. the blood group substance, then recovering (I) from the supernatant liq. The starting soln. is esp. derived from human placenta or retroplacental blood and has protein concn. 5-40 g/l (>=50% of this is albumin) and the inorganic salt concn. expressed as NaCl is =50 g/l. A pref. (II) has mean mol. wt. 2000-10000. (I) is used to treat acute haemorrhage, shock, burns protein deficiency, hyporpoteinaemia etc. It is prepd. free from blood group substances and hypotensive components so can be safely used to make solns. for infusion. The method does not require precipitants which may denature proteins nor very low temps.
FR7723471A 1977-04-12 1977-07-29 Pure human albumin recovery esp. from placental tissue - by pptn. of impurities with polyethylene glycol, for treating haemorrhage, shock etc. Granted FR2387240A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4176277A JPS53127808A (en) 1977-04-12 1977-04-12 Preparation of human albumin

Publications (2)

Publication Number Publication Date
FR2387240A1 true FR2387240A1 (en) 1978-11-10
FR2387240B1 FR2387240B1 (en) 1980-02-15

Family

ID=12617404

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7723471A Granted FR2387240A1 (en) 1977-04-12 1977-07-29 Pure human albumin recovery esp. from placental tissue - by pptn. of impurities with polyethylene glycol, for treating haemorrhage, shock etc.

Country Status (8)

Country Link
JP (1) JPS53127808A (en)
AT (1) AT365074B (en)
BG (1) BG31214A3 (en)
DE (1) DE2733923C3 (en)
FR (1) FR2387240A1 (en)
HU (1) HU174149B (en)
SU (1) SU1127525A3 (en)
YU (1) YU40170B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59169055U (en) * 1983-04-27 1984-11-12 松下電器産業株式会社 electronic parts equipment
US5525519A (en) * 1992-01-07 1996-06-11 Middlesex Sciences, Inc. Method for isolating biomolecules from a biological sample with linear polymers
JP2721961B2 (en) * 1996-03-11 1998-03-04 株式会社ミドリ十字 Blood products

Also Published As

Publication number Publication date
YU186077A (en) 1983-04-30
DE2733923C3 (en) 1980-02-07
JPS53127808A (en) 1978-11-08
YU40170B (en) 1985-08-31
FR2387240B1 (en) 1980-02-15
ATA549977A (en) 1981-05-15
AT365074B (en) 1981-12-10
HU174149B (en) 1979-11-28
SU1127525A3 (en) 1984-11-30
JPS572689B2 (en) 1982-01-18
DE2733923B2 (en) 1979-06-07
DE2733923A1 (en) 1978-10-19
BG31214A3 (en) 1981-11-16

Similar Documents

Publication Publication Date Title
ATE294864T1 (en) OUTER MEMBRANE PROTEIN OF HAEMOPHILUS
DE69020794D1 (en) Enzymatic removal of an amino terminal protein sequence.
DE3279807D1 (en) Process for heat treatment of aqueous solution containing human blood coagulation factor viii
DE3587941D1 (en) DEVICE FOR PROVISIONAL REPERFUSION TREATMENT OF HEART ATTACK SYMPTOMS.
DE3750451D1 (en) RECOMBINANT HUMAN ENDOTHEL CELL GROWTH FACTOR.
DK157724C (en) DIPEPTIME FOOD-METAL COMPLEX AND ITS USE
ES2062241T3 (en) PURIFICATION METHOD OF HUMAN SERIC ALBUMIN.
EP0263608A3 (en) Protein having anticoagulant and antimetastatic properties
DE69228015T2 (en) Antithrombin polypeptides
DK573587A (en) PROCEDURE FOR PREPARING A FACTOR VIII (AHF) CONTAINING FRACTION
ATE111480T1 (en) METHOD OF RECOVERING RECOMBINANT PROTEINS USING FLOCCULING AGENTS.
JPS5359018A (en) Concentrated xiii-th blood coagulating factor derived from human placentaand its preparation
FR2387240A1 (en) Pure human albumin recovery esp. from placental tissue - by pptn. of impurities with polyethylene glycol, for treating haemorrhage, shock etc.
DE69529845T2 (en) HEAT TREATMENT OF BLOOD PLASMA PROTEINS
DE69029471D1 (en) RECOVERY PROCESS OF MICROBYLED CHYMOSINE
ES2139660T3 (en) VIRAL MORPHOGENESIS INHIBITION METHOD.
SE8501170L (en) PROCEDURE
FR2340092A2 (en) Analgesic (N)-thiazolyl-quinoline carboxamides - prepd. from the corresp. quinoline carboxylic acid and (2)-amino-thiazole
DK0477198T3 (en) Method for Extracting Recombinant Proteins
GR3033698T3 (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections.
ATE44750T1 (en) PROCESS FOR PREPARING AN ANTI-HEMOPHILIA FACTOR CONCENTRATE.
DE3782319D1 (en) METHOD FOR PRODUCING HIGH-PURITY ZIRCONOXIDE FROM LOW-SILICONE ZIRCONIUM-IRONING SUBSTANCES.
ATE310745T1 (en) CRYSTALLIZATION OF A PROTEIN WITH A SULFUR SALT
ATE35533T1 (en) PROCESS FOR RECOVERING PURE BENZOIC ACID.
KR910006477A (en) Purification Method of Plasminogen Activator-Exhibit 2 (PAI-2)

Legal Events

Date Code Title Description
ST Notification of lapse